Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 158 of 1,261
  1. US 11814447

    Peptide ligands for binding to EphA2

    BicycleRD Limited Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  2. US 11813320

    Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  3. US 11814431

    B7-H4 antibodies and methods of use thereof

    Five Prime Therapeutics, Inc. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  4. US 11813359

    Sustained release olanzapine formulations

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  5. US 11813358

    Lipid nanodisc formation by polymers having a pendant hydrophobic group

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  6. US 11813341

    Dental product with enhanced toughness

    KURARAY NORITAKE DENTAL INC. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  7. US 11814373

    Methods and compounds for restoring mutant p53 function

    PMV PHARMACEUTICALS, INC. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  8. US 11814427

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  9. US 11813316

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  10. US 11813241

    Multi-arm polymeric prodrug conjugates of taxane-based compounds

    Nektar Therapeutics Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  11. US 11814371

    Heterocyclic compound

    Medshine Discovery Inc. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  12. US 11814622

    OPA1 antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  13. US 11814445

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  14. US 11814659

    Tunable nanoscale cages from self-assembling DNA and protein building blocks

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  15. US 11814624

    Targeted non-viral DNA insertions

    The Regents of the University of California Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  16. US 11813257

    Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors

    Disc Medicine, Inc. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  17. US 11813357

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  18. US 11814432

    Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof

    SANGAMO THERAPEUTICS FRANCE Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  19. US 11813335

    Pyrrolobenzodiazepine-antibody conjugates

    ADC THERAPEUTICS SA Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  20. US 11814376

    Hepatitis b core protein modulators

    ASSEMBLY BIOSCIENCES, INC. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  21. US 11813319

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  22. US 11814657

    Modified DNase and uses thereof

    Protalix Ltd. Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  23. US 11813235

    Guanfacine as an anti-virulence agent

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted
  24. US 11813123

    Ultrasound responsive micro-composite markers

    The Regents of the University of California Β· Granted Nov 14, 2023 Β· Expires Nov 9, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.